Cite
Aliskiren in type 2 diabetes and cardiorenal end points.
MLA
Pfeffer, Marc A., et al. “Aliskiren in Type 2 Diabetes and Cardiorenal End Points.” New England Journal of Medicine, vol. 368, no. 11, Mar. 2013, pp. 1065–66. EBSCOhost, https://doi.org/10.1056/NEJMc1300257.
APA
Pfeffer, M. A., Brenner, B. M., & McMurray, J. J. V. (2013). Aliskiren in type 2 diabetes and cardiorenal end points. New England Journal of Medicine, 368(11), 1065–1066. https://doi.org/10.1056/NEJMc1300257
Chicago
Pfeffer, Marc A, Barry M Brenner, and John J V McMurray. 2013. “Aliskiren in Type 2 Diabetes and Cardiorenal End Points.” New England Journal of Medicine 368 (11): 1065–66. doi:10.1056/NEJMc1300257.